• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quality improvement in medicines regulation: a retrospective analysis of the Pharmacy Board of Sierra Leone before and during quality management system implementation.药品监管质量改进:塞拉利昂药剂师管理局在实施质量管理体系之前和期间的回顾性分析。
BMC Health Serv Res. 2024 Sep 3;24(1):1020. doi: 10.1186/s12913-024-11452-8.
2
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
3
Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.埃塞俄比亚的药品监管框架:对其法律基础与实施情况的批判性评估
Ethiop J Health Sci. 2016 May;26(3):259-76. doi: 10.4314/ejhs.v26i3.9.
4
Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone.资源有限环境下的药物警戒系统:塞拉利昂的一项评估性案例研究
J Pharm Policy Pract. 2019 Jun 11;12:13. doi: 10.1186/s40545-019-0173-2. eCollection 2019.
5
Patients satisfaction with free healthcare pharmaceutical services in Sierra Leone: a national cross-sectional study.塞拉利昂免费医疗药品服务患者满意度:全国横断面研究。
Int J Clin Pharm. 2021 Jun;43(3):556-565. doi: 10.1007/s11096-020-01163-5. Epub 2020 Oct 6.
6
The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda.年轻的国家药品监管当局确保药品质量的能力:卢旺达的情况
J Pharm Policy Pract. 2022 Nov 24;15(1):90. doi: 10.1186/s40545-022-00492-2.
7
Pilot drug and therapeutic committee programme in Sierra Leone: A descriptive mixed method study.塞拉利昂先导药物和治疗委员会方案:一项描述性混合方法研究。
Br J Clin Pharmacol. 2023 Jan;89(1):20-33. doi: 10.1111/bcp.14716. Epub 2021 Feb 10.
8
Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.防范假药的公共卫生干预措施:对国际、国家和地方政策的系统评价
Health Policy Plan. 2016 Dec;31(10):1448-1466. doi: 10.1093/heapol/czw062. Epub 2016 Jun 16.
9
Capacity Assessment of the National Medicines Regulatory Authority in a Low -Income Country.国家药品监督管理局在低收入国家的能力评估。
Ther Innov Regul Sci. 2024 Nov;58(6):1053-1060. doi: 10.1007/s43441-024-00683-w. Epub 2024 Aug 4.
10
Exploring the Knowledge and Perception of Generic Medicines among Final Year Undergraduate Medical, Pharmacy, and Nursing Students in Sierra Leone: A Comparative Cross-Sectional Approach.探索塞拉利昂医学、药学和护理学本科最后一年学生对仿制药的了解和认知:一种比较横断面研究方法。
Pharmacy (Basel). 2018 Jan 4;6(1):3. doi: 10.3390/pharmacy6010003.

本文引用的文献

1
Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.非洲药品监管协调倡议中的最佳实践:监管机构与药品制造商的观点
PLOS Glob Public Health. 2023 Apr 26;3(4):e0001651. doi: 10.1371/journal.pgph.0001651. eCollection 2023.
2
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.非洲药品管理局的设立:进展、挑战与监管准备情况
J Pharm Policy Pract. 2021 Mar 8;14(1):29. doi: 10.1186/s40545-020-00281-9.
3
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.医疗产品监管协调:提高东非共同体监管能力的关键因素。
BMC Public Health. 2021 Jan 21;21(1):187. doi: 10.1186/s12889-021-10169-1.
4
Identification of the awareness level by the public of Arab countries toward COVID-19: cross-sectional study following an outbreak.阿拉伯国家公众对新型冠状病毒肺炎的认知水平识别:疫情爆发后的横断面研究
J Pharm Policy Pract. 2020 Jul 15;13:43. doi: 10.1186/s40545-020-00247-x. eCollection 2020.
5
Global Contributors to Antibiotic Resistance.抗生素耐药性的全球影响因素
J Glob Infect Dis. 2019 Jan-Mar;11(1):36-42. doi: 10.4103/jgid.jgid_110_18.
6
The South African Regulatory System: Past, Present, and Future.南非监管体系:过去、现在与未来。
Front Pharmacol. 2018 Dec 4;9:1407. doi: 10.3389/fphar.2018.01407. eCollection 2018.
7
Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers.针对罕见癌症、儿童癌症及常见癌症分子亚型的抗癌疗法的全球发展情况。
J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00092.
8
Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.利用反射红外光谱法对药物成分进行定量筛选,快速识别劣质和假冒药品。
PLoS One. 2018 Aug 10;13(8):e0202059. doi: 10.1371/journal.pone.0202059. eCollection 2018.
9
Medicines Regulation in Africa: Current State and Opportunities.非洲的药品监管:现状与机遇
Pharmaceut Med. 2017;31(6):383-397. doi: 10.1007/s40290-017-0210-x. Epub 2017 Nov 3.
10
Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs.提供优质计划生育服务:美国疾病预防控制中心和人口事务办公室的建议。
MMWR Recomm Rep. 2014 Apr 25;63(RR-04):1-54.

药品监管质量改进:塞拉利昂药剂师管理局在实施质量管理体系之前和期间的回顾性分析。

Quality improvement in medicines regulation: a retrospective analysis of the Pharmacy Board of Sierra Leone before and during quality management system implementation.

机构信息

Faculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Pharmacy Board of Sierra Leone, Freetown, Sierra Leone.

出版信息

BMC Health Serv Res. 2024 Sep 3;24(1):1020. doi: 10.1186/s12913-024-11452-8.

DOI:10.1186/s12913-024-11452-8
PMID:39227931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11373281/
Abstract

BACKGROUND

National Medicines Regulatory Authorities like the Pharmacy Board of Sierra Leone are responsible for protecting and promoting public health, implementing regulatory standards, and maintaining a supply chain with an assured supply of medical products that are safe, effective, and of good quality. This retrospective study assesses the identification of substandard and falsified medicines, the changes in the functions and key indicators of assessment, and the quality improvement changes of the Pharmacy Board of Sierra Leone.

METHODS

Data was obtained from 2013 to 2021 records using a data collection tool to collate and review all relevant information to address the different objectives. All data were sourced from the Department of Quality Assurance and the Department of Enforcement and Narcotics at the Pharmacy Board of Sierra Leone. The review also included, identified substandard and falsified medicines, the World Health Organisation Global benchmarking self-assessment tool, and internal and external audit records of the quality management system of all twelve departments of the Pharmacy Board of Sierra Leone.

RESULTS

The study showed marked changes in identifying substandard and falsified medicines by the Pharmacy Board of Sierra Leone during ISO 9001:2015 implementation (2017- 2020) compared to Pre-ISO 9001:2015 implementation (2013- 2016). Critical functions of the Pharmacy Board of Sierra Leone from the assessment of the WHO GBT ML in 2016 and 2021 showed that several indicators had been addressed during ISO 9001:2015 certification with improvement in the level of maturity for the quality management systems and Pharmacovigilance functions. There was also an improvement in identifying non-conformances and a commitment to continuous improvement of processes during ISO 9001:2015 implementation.

CONCLUSIONS

This study revealed that regular checks through standard assessment, internal audits, and standard management review processes that generate follow-up actions, timelines, and a commitment to identifying correction, and corrective actions for non-conformances are essential quality improvement tools for the efficient functioning of an institution (Pharmacy Board of Sierra Leone). Our study revealed that commitment to continuous implementation of proper quality management system could significantly improve institutional efficiency, thereby improving service delivery and customer satisfaction.

摘要

背景

像塞拉利昂药剂师理事会这样的国家药品监管机构负责保护和促进公众健康,执行监管标准,并维持一个供应链,确保供应安全、有效和高质量的医疗产品。这项回顾性研究评估了识别劣药和假药的情况、功能和评估关键指标的变化,以及塞拉利昂药剂师理事会的质量改进变化。

方法

使用数据收集工具获取 2013 年至 2021 年的记录,以整理和审查所有相关信息,以解决不同的目标。所有数据均来自塞拉利昂药剂师理事会质量保证司和执法及麻醉品司。审查还包括识别劣药和假药、世界卫生组织全球基准自我评估工具,以及塞拉利昂药剂师理事会所有 12 个部门的质量管理体系的内部和外部审计记录。

结果

该研究表明,在实施 ISO 9001:2015 期间(2017-2020 年),塞拉利昂药剂师理事会在识别劣药和假药方面发生了显著变化,而在实施 ISO 9001:2015 之前(2013-2016 年)则没有。2016 年和 2021 年世界卫生组织全球贸易伙伴关系评估中的 WHO GBT ML 关键功能表明,在 ISO 9001:2015 认证期间,已经解决了几个指标,质量管理体系和药物警戒功能的成熟度水平有所提高。在实施 ISO 9001:2015 期间,也提高了识别不合格项的能力,并承诺不断改进流程。

结论

本研究表明,定期通过标准评估、内部审计和标准管理评审进行检查,生成后续行动、时间表,并承诺确定纠正措施和不合格项的纠正措施,是机构(塞拉利昂药剂师理事会)高效运作的重要质量改进工具。我们的研究表明,持续实施适当的质量管理体系的承诺可以显著提高机构效率,从而改善服务交付和客户满意度。